Threshold Pharmaceuticals

Organization

South San Francisco, CA, US

Ticker Symbols

NASDAQ:THLD

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Administration of hypoxia activated prodrugs in combination with Ch...
- Patent number 9,254,299
- Issue date Feb 9, 2016
- Threshold Pharmaceuticals, Inc.
- Charles Hart
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phosphoramidate alkylator prodrugs
- Patent number 9,226,932
- Issue date Jan 5, 2016
- Threshold Pharmaceuticals, Inc.
- Mark Matteucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-cancer therapies
- Patent number 9,205,098
- Issue date Dec 8, 2015
- Threshold Pharmaceuticals
- George Tidmarsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer using hypoxia activated prodrugs
- Patent number 8,946,275
- Issue date Feb 3, 2015
- Threshold Pharmaceuticals, Inc.
- John G. Curd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer with glufosfamide in patients not receiving ins...
- Patent number 8,765,690
- Issue date Jul 1, 2014
- Threshold Pharmaceuticals, Inc.
- Damian Handisides
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phosphoramidate alkylator prodrugs
- Patent number 8,664,204
- Issue date Mar 4, 2014
- Threshold Pharmaceuticals, Inc.
- Mark Matteucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Camptothecin derivatives
- Patent number 8,575,188
- Issue date Nov 5, 2013
- Threshold Pharmaceuticals, Inc.
- Xiaohong Cai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phosphoramidate alkylator prodrugs for the treatment of cancer
- Patent number 8,552,048
- Issue date Oct 8, 2013
- Threshold Pharmaceuticals, Inc.
- Steve Ammons
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phosphoramidate alkylator prodrugs
- Patent number 8,507,464
- Issue date Aug 13, 2013
- Threshold Pharmaceuticals, Inc.
- Mark Matteucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-cancer therapies
- Patent number 8,318,683
- Issue date Nov 27, 2012
- Threshold Pharmaceuticals, Inc.
- George Tidmarsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hypoxia activated drugs of nitrogen mustard alkylators
- Patent number 8,309,554
- Issue date Nov 13, 2012
- Threshold Pharmaceuticals
- Jason Lewis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods for treating cancer
- Patent number 8,299,088
- Issue date Oct 30, 2012
- Threshold Pharmaceuticals, Inc.
- Mark Matteucci
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Phosphoramidate alkylator prodrugs
- Patent number 8,003,625
- Issue date Aug 23, 2011
- Threshold Pharmaceuticals, Inc.
- Mark Matteucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for determining susceptibility of tumor to treatment with an...
- Patent number 7,560,230
- Issue date Jul 14, 2009
- Threshold Pharmaceuticals, Inc.
- George Tidmarsh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for treating cancer
- Patent number 7,550,496
- Issue date Jun 23, 2009
- Threshold Pharmaceuticals, Inc.
- Mark Matteucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for treating cancer
- Patent number 7,001,888
- Issue date Feb 21, 2006
- Threshold Pharmaceuticals, Inc.
- George Tidmarsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for cancer imaging
- Patent number 6,989,140
- Issue date Jan 24, 2006
- Threshold Pharmaceuticals, Inc.
- George Tidmarsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of benign prostatic hyperplasia
- Patent number 6,989,400
- Issue date Jan 24, 2006
- Threshold Pharmaceuticals, Inc.
- George Tidmarsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of cancer with 2-deoxyglucose
- Patent number 6,979,675
- Issue date Dec 27, 2005
- Threshold Pharmaceuticals, Inc.
- George Tidmarsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PREDICTIVE BIOMARKER FOR HYPOXIA-ACTIVATED PRODRUG THERAPY
- Publication number 20180334716
- Publication date Nov 22, 2018
- Merck Patent GmbH
- Brian A. Elenbaas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AZIRIDINE CONTAINING DNA ALKYLATING AGENTS
- Publication number 20180169064
- Publication date Jun 21, 2018
- Threshold Pharmaceuticals, Inc.
- Mark Matteucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KINASE INHIBITOR PRODRUG FOR THE TREATMENT OF CANCER
- Publication number 20170360790
- Publication date Dec 21, 2017
- Auckland UniServices Limited
- Adam Vorn Patterson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CANCER
- Publication number 20170232017
- Publication date Aug 17, 2017
- Threshold Pharmaceuticals, Inc.
- Stewart Kroll
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TH-302 SOLID FORMS AND METHODS RELATED THERETO
- Publication number 20170210769
- Publication date Jul 27, 2017
- Threshold Pharmaceuticals, Inc.
- Jian-Xin Duan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-Cancer Therapies
- Publication number 20170157161
- Publication date Jun 8, 2017
- Threshold Pharmaceuticals, Inc.
- George Tidmarsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREDICTIVE AND RESPONSE BIOMARKER FOR TH-302 ANTI-CANCER THERAPY
- Publication number 20160296538
- Publication date Oct 13, 2016
- Threshold Pharmaceuticals, Inc.
- Charles Hart
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF PANCREATIC CANCER WITH A COMBINATION OF A HYPOXIA-ACTI...
- Publication number 20160158253
- Publication date Jun 9, 2016
- Threshold Pharmaceuticals, Inc.
- CHARLES P. HART
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADMINISTRATION OF GLUFOSFAMIDE FOR THE TREATMENT OF CANCER
- Publication number 20160143929
- Publication date May 26, 2016
- Threshold Pharmaceuticals, Inc.
- John G. Curd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Cancer
- Publication number 20160045522
- Publication date Feb 18, 2016
- Threshold Pharmaceuticals, Inc.
- Stewart Kroll
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment of Cancer with Glufosfamide in Patients Not Receiving Ins...
- Publication number 20150272973
- Publication date Oct 1, 2015
- Threshold Pharmaceuticals, Inc.
- Damian Handisides
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF CANCER USING HYPOXIA ACTIVATED PRODRUGS
- Publication number 20150258125
- Publication date Sep 17, 2015
- THRESHOLD PHARMACEUTICALS, INC.
- John G. Curd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HYPOXIA ACTIVATED PRODRUGS AND MTOR INHIBITORS FOR TREATING CANCER
- Publication number 20150005262
- Publication date Jan 1, 2015
- Threshold Pharmaceuticals, Inc.
- Charles Hart
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS IN COMBINATION WITH CH...
- Publication number 20150005263
- Publication date Jan 1, 2015
- Threshold Pharmaceuticals, Inc.
- Charles Hart
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREDICTIVE BIOMARKER FOR HYPOXIA-ACTIVATED PRODRUG THERAPY
- Publication number 20150005264
- Publication date Jan 1, 2015
- Threshold Pharmaceuticals, Inc.
- Charles Hart
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Phosphoramidate Alkylator Prodrugs
- Publication number 20140170240
- Publication date Jun 19, 2014
- Threshold Pharmaceuticals, Inc.
- Mark Matteucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING CANCER
- Publication number 20140171389
- Publication date Jun 19, 2014
- Threshold Pharmaceuticals, Inc.
- Charles Hart
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
UNIT DOSE FORM FOR ORAL ADMINISTRATION
- Publication number 20140072624
- Publication date Mar 13, 2014
- Threshold Pharmaceuticals, Inc.
- Donald Jung
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHOSPHORAMIDATE ALKYLATOR PRODRUGS
- Publication number 20130303778
- Publication date Nov 14, 2013
- THRESHOLD PHARMACEUTICALS, INC.
- Mark Matteucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF BLOOD CANCER
- Publication number 20130296273
- Publication date Nov 7, 2013
- THRESHOLD PHARMACEUTICALS, INC.
- John Curd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-Cancer Therapies
- Publication number 20130045944
- Publication date Feb 21, 2013
- Threshold Pharmaceuticals, Inc.
- George Tidmarsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CAMPTOTHECIN DERIVATIVES
- Publication number 20120165522
- Publication date Jun 28, 2012
- THRESHOLD PHARMACEUTICALS, INC.
- Xiaohong Cai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Phosphoramidate Alkylator Prodrugs
- Publication number 20110251159
- Publication date Oct 13, 2011
- Threshold Pharmaceuticals, Inc.
- Mark Matteucci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hypoxia Activated Drugs Of Nitrogen Mustard Alkylators
- Publication number 20110190310
- Publication date Aug 4, 2011
- THRESHOLD PHARMACEUTICALS, INC.
- Jason Lewis
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Glufosfamide combination therapy
- Publication number 20110182909
- Publication date Jul 28, 2011
- Threshold Pharmaceuticals, Inc.
- George Tidmarsh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHOSPHORAMIDATE ALKYLATOR PRODRUGS FOR THE TREATMENT OF CANCER
- Publication number 20100183742
- Publication date Jul 22, 2010
- Threshold Pharmaceuticals, Inc.
- Steve Ammons
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLUFOSFAMIDE COMBINATION THERAPY
- Publication number 20100104549
- Publication date Apr 29, 2010
- Threshold Pharmaceuticals, Inc.
- Damian Handisides
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tubulin Binding Anti Cancer Agents And Prodrugs Thereof
- Publication number 20090042820
- Publication date Feb 12, 2009
- Threshold Pharmaceuticals, Inc.
- Mark Matteucci
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Analytical Methods For 2-Deoxy-D-Glucose
- Publication number 20080276694
- Publication date Nov 13, 2008
- Threshold Pharmaceutical, Inc.
- Michael Li
- G01 - MEASURING TESTING
Information Patent Application
Topoisomerase Inhibitors and Prodrugs
- Publication number 20080214576
- Publication date Sep 4, 2008
- Threshold Pharmaceuticals, Inc.
- Mark Matteucci
- C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks

Information Trademark
85777049 - HYPOXIN
- Serial number 85777049
- Filing date Nov 12, 2012
- Threshold Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78389589 - THRESHOLD
- Serial number 78389589
- Filing date Mar 23, 2004
- Threshold Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78389593 - THRESHOLD
- Serial number 78389593
- Filing date Mar 23, 2004
- Threshold Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78389595 - METABOLIC TARGETING
- Serial number 78389595
- Registration number 3522409
- Filing date Mar 23, 2004
- Threshold Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78389594 - GLUFOS
- Serial number 78389594
- Registration number 3009609
- Filing date Mar 23, 2004
- Threshold Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78341054 - THRESHOLD PHARMACEUTICALS
- Serial number 78341054
- Registration number 3009488
- Filing date Dec 15, 2003
- Threshold Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78341062 - THRESHOLD PHARMACEUTICALS
- Serial number 78341062
- Registration number 3009489
- Filing date Dec 15, 2003
- Threshold Pharmaceuticals, Inc.
- 5 - Pharmaceutical and veterinary preparations

Threshold Pharmaceuticals

Organization

Ticker Symbols

Patents Grantslast 30 patents

Administration of hypoxia activated prodrugs in combination with Ch...

Phosphoramidate alkylator prodrugs

Anti-cancer therapies

Treatment of cancer using hypoxia activated prodrugs

Treatment of cancer with glufosfamide in patients not receiving ins...

Phosphoramidate alkylator prodrugs

Camptothecin derivatives

Phosphoramidate alkylator prodrugs for the treatment of cancer

Phosphoramidate alkylator prodrugs

Anti-cancer therapies

Hypoxia activated drugs of nitrogen mustard alkylators

Compositions and methods for treating cancer

Phosphoramidate alkylator prodrugs

Method for determining susceptibility of tumor to treatment with an...

Compositions and methods for treating cancer

Compositions and methods for treating cancer

Methods for cancer imaging

Treatment of benign prostatic hyperplasia

Treatment of cancer with 2-deoxyglucose

Patents Applicationslast 30 patents

PREDICTIVE BIOMARKER FOR HYPOXIA-ACTIVATED PRODRUG THERAPY

AZIRIDINE CONTAINING DNA ALKYLATING AGENTS

KINASE INHIBITOR PRODRUG FOR THE TREATMENT OF CANCER

TREATMENT OF CANCER

TH-302 SOLID FORMS AND METHODS RELATED THERETO

Anti-Cancer Therapies

PREDICTIVE AND RESPONSE BIOMARKER FOR TH-302 ANTI-CANCER THERAPY

TREATMENT OF PANCREATIC CANCER WITH A COMBINATION OF A HYPOXIA-ACTI...

ADMINISTRATION OF GLUFOSFAMIDE FOR THE TREATMENT OF CANCER

Treatment of Cancer

Treatment of Cancer with Glufosfamide in Patients Not Receiving Ins...

TREATMENT OF CANCER USING HYPOXIA ACTIVATED PRODRUGS

HYPOXIA ACTIVATED PRODRUGS AND MTOR INHIBITORS FOR TREATING CANCER

ADMINISTRATION OF HYPOXIA ACTIVATED PRODRUGS IN COMBINATION WITH CH...

PREDICTIVE BIOMARKER FOR HYPOXIA-ACTIVATED PRODRUG THERAPY

Phosphoramidate Alkylator Prodrugs

METHODS FOR TREATING CANCER

UNIT DOSE FORM FOR ORAL ADMINISTRATION

PHOSPHORAMIDATE ALKYLATOR PRODRUGS

TREATMENT OF BLOOD CANCER

Anti-Cancer Therapies

CAMPTOTHECIN DERIVATIVES

Phosphoramidate Alkylator Prodrugs

Hypoxia Activated Drugs Of Nitrogen Mustard Alkylators

Glufosfamide combination therapy

PHOSPHORAMIDATE ALKYLATOR PRODRUGS FOR THE TREATMENT OF CANCER

GLUFOSFAMIDE COMBINATION THERAPY

Tubulin Binding Anti Cancer Agents And Prodrugs Thereof

Analytical Methods For 2-Deoxy-D-Glucose

Topoisomerase Inhibitors and Prodrugs

Trademarklast 30 trademarks

85777049 - HYPOXIN

78389589 - THRESHOLD

78389593 - THRESHOLD

78389595 - METABOLIC TARGETING

78389594 - GLUFOS

78341054 - THRESHOLD PHARMACEUTICALS

78341062 - THRESHOLD PHARMACEUTICALS